FDA Approval Sends Shares on a Tear
25 9월 2023 - 11:30PM
AllPennyStocks.com
The morning opened up on a high note for this dually-listed
company as it announced U.S. Food and Drug Administration (FDA)
approval of its Metronidazole Oral Suspension 500mg/5mL ( ATI-1501
)....
To read the full story on AllPennyStocks.com, click
here.
Appili Therapeutics (TSX:APLI)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024
Appili Therapeutics (TSX:APLI)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024